Evidence map›Paper›PMID 40590901›Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2025

Implementing pharmacist-led home medicines reviews within fracture liaison services for better post-fracture care: a qualitative study of patient and practitioner experience.

Michael J Bennett, Jacqueline R Center, Stephen Carter, Rebekah Moles, Lin Perry

Abstract read
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Follow-on osteoporosis therapy after denosumab discontinuation among Medicare beneficiaries.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael J BennettDepartment of Endocrinology, Prince of Wales Hospital, Randwick, NSW, Australia. michael.j.bennett@unsw.edu.au.ORCID http://orcid.org/0000-0003-4320-2684
Jacqueline R CenterThe Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Stephen CarterSydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Rebekah MolesSydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Lin PerryFaculty of Health, University of Technology Sydney, Ultimo, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Home medicines reviews present a novel intervention supporting continuity of care between fracture liaison services and primary care. Home medicines review pharmacists deliver multifaceted, collaborative interventions that can bridge gaps in care, promote patient empowerment, facilitate a GP-patient discussion about bone health, and improve coordination of care. PURPOSE: Medication review has potential to reduce the risk of falls and fractures and improve transition of care from a specialist fracture liaison service to primary care. This study was designed to examine and evaluate the implementation of a home medicines review into fracture liaison services in Australia. Study objectives were to (1) explore how home medicines reviews might facilitate the healthcare transition from fracture liaison service to primary care and (2) identify factors required to achieve this.

methodsThis was a qualitative descriptive study nested within a randomised trial (reported elsewhere). Semi-structured interviews were conducted with patients and healthcare practitioners responsible for providing osteoporosis services. Formative and early-stage data collection occurred September 2022 to January 2024. Thematic analysis was employed inductively (data-driven) and directed content analysis was applied deductively (theory-driven) using the consolidated framework for implementation research (CFIR) domains to frame factors affecting home medicines review implementation.

resultsFifty-six interviews were performed: 25 with pharmacists, 14 with fracture liaison service clinicians, seven with GPs, and ten with patients. Participants perceived home medicines review pharmacists to be uniquely positioned to favourably influence the transition to primary care by (1) identifying gaps in care, (2) promoting patient empowerment, (3) facilitating a GP-patient discussion about bone health, and (4) improving coordination of care. Factors affecting home medicines review implementation related to CFIR domains of the individuals (patient and GP engagement and willingness to accept advice, patient preparedness, GP confidence deprescribing), the innovation (hospital endorsement of home medicines review reports, perception of intervention value, embedded administrative assistants, pharmacist expertise), the inner setting (role clarity, multidisciplinary teamwork culture, and patient-centred focus, scheduling practices, and communication systems), and outer setting (access to telehealth services, a network of mobile pharmacists, and appropriate remuneration systems).

conclusionHome medicines review pharmacists delivering multifaceted, collaborative, and patient-centred interventions can support effective transition of care between fracture liaison services and primary care. Further work should test their integration into fracture liaison service models within routine care environments.

Indexed as

Bone Density Conservation AgentsMedication ReconciliationMedication Therapy ManagementOsteoporotic FracturesPharmacistsAgedAttitude of Health PersonnelAustraliaContinuity of Patient CareFemaleHumansMaleMiddle AgedOsteoporosisPrimary Health CareProfessional RoleBone Density Conservation AgentsFracture liaison serviceHealthcare transitionsHome medicines reviewModels of careOsteoporosis

Identifiers

PMID40590901
PMCPMC12611987

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.